GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Total Stockholders Equity

Nortem Biogroup (XPAR:MLBIO) Total Stockholders Equity : €6.62 Mil (As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Total Stockholders Equity?

Nortem Biogroup's Total Stockholders Equity for the quarter that ended in Dec. 2022 was €6.62 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Nortem Biogroup's Book Value per Share for the quarter that ended in Dec. 2022 was €2.57. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Nortem Biogroup's Debt-to-Equity for the quarter that ended in Dec. 2022 was 0.96.

Nortem Biogroup Total Stockholders Equity Historical Data

The historical data trend for Nortem Biogroup's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Total Stockholders Equity Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
Total Stockholders Equity
5.14 6.62

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
Total Stockholders Equity 5.14 6.62

Nortem Biogroup  (XPAR:MLBIO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Nortem Biogroup's Book Value per Share for the quarter that ended in Dec. 2022 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(6.616-0)/2.579
=2.57

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Nortem Biogroup's Debt-to-Equity for the quarter that ended in Dec. 2022 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(2.976 + 3.385) / 6.616
=0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nortem Biogroup Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Total Stockholders Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Website
https://www.nortembiogroup.com
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines